Rehan Verjee's most recent trade in Tyra Biosciences Inc was a trade of 971 Common Stock done at an average price of $20.6 . Disclosure was reported to the exchange on Sept. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tyra Biosciences Inc | Mr. Rehan Verjee | Director | Purchase of securities on an exchange or from another person at price $ 20.60 per share. | 09 Sep 2026 | 971 | 971 | - | 20.6 | 20,000 | Common Stock |
| Tyra Biosciences Inc | Mr. Rehan Verjee | Director | 28 May 2026 | 13,160 | 13,160 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Mr. Rehan Verjee | Director | 29 May 2025 | 22,200 | 22,200 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Mr. Rehan Verjee | Director | 29 May 2024 | 18,600 | 18,600 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Mr. Rehan Verjee | Director | 31 May 2023 | 14,500 | 14,500 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Mr. Rehan Verjee | Director | 13 Jun 2022 | 14,500 | 14,500 | - | - | Stock Option (Right to Buy) |